Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Moat Score: 0/10 (As of Jul. 13, 2026)


SHSE:600671 Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd SHSE:600671
54 GF Score
Price ¥21.13
GF Value ¥14.96
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Moat Score?

Hangzhou TianMuShan Pharmaceutical Enterprise Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Hangzhou TianMuShan Pharmaceutical Enterprise Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Hangzhou TianMuShan Pharmaceutical Enterprise Co might have No Moat - No discernible moat.


Hangzhou TianMuShan Pharmaceutical Enterprise Co  (SHSE:600671) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Hangzhou TianMuShan Pharmaceutical Enterprise Co Moat Score Related Terms

SHSE:600671
54GF Score
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd SHSE:600671
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou TianMuShan Pharmaceutical Enterprise Co stock appears to be overvalued. The current stock price of ¥21.13 is trading 41.2% above its estimated GF Value™ of ¥14.96. GuruFocus considers Hangzhou TianMuShan Pharmaceutical Enterprise Co to be Significantly Overvalued.

Key valuation signals for SHSE:600671:

  • Moat Score: 0
  • GF Value™: ¥14.96 vs. price of ¥21.13 (41.2% above fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou TianMuShan Pharmaceutical Enterprise Co Business Description

Address No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311200
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
54GF Score

Get the complete analysis for SHSE:600671

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.13
Price
¥14.96
GF Value